Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies
ABSTRACT Twelve thiazole‐pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2‐((4‐acetylphenyl)amino)‐4‐methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided...
Saved in:
Published in | Chemical biology & drug design Vol. 105; no. 3; pp. e70090 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
HOBOKEN
Wiley
01.03.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 1747-0277 1747-0285 1747-0285 |
DOI | 10.1111/cbdd.70090 |
Cover
Loading…
Abstract | ABSTRACT
Twelve thiazole‐pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2‐((4‐acetylphenyl)amino)‐4‐methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge‐transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc‐1, HT‐29, MCF‐7) and the non‐cancerous (WI‐38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc‐1 and MCF‐7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC50 = 61 μg/μL), comparable to the reference drug amantadine (TC50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H‐bonding and π‐π stacking, with binding affinities between −4.8558 and − 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug‐like characteristics, but analogues 4a–d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. |
---|---|
AbstractList | ABSTRACT
Twelve thiazole‐pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2‐((4‐acetylphenyl)amino)‐4‐methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge‐transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc‐1, HT‐29, MCF‐7) and the non‐cancerous (WI‐38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc‐1 and MCF‐7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC50 = 61 μg/μL), comparable to the reference drug amantadine (TC50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H‐bonding and π‐π stacking, with binding affinities between −4.8558 and − 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug‐like characteristics, but analogues 4a–d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. Twelve thiazole‐pyrazole analogues 4 , 6 , and 8 were synthesized by introducing various pyrazole systems into the core, 2‐((4‐acetylphenyl)amino)‐4‐methylthiazole ( 2 ), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge‐transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc‐1, HT‐29, MCF‐7) and the non‐cancerous (WI‐38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc‐1 and MCF‐7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC 50 = 61 μg/μL), comparable to the reference drug amantadine (TC 50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H‐bonding and π‐π stacking, with binding affinities between −4.8558 and − 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug‐like characteristics, but analogues 4a–d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. Twelve thiazole-pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2-((4-acetylphenyl)amino)-4-methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge-transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc-1, HT-29, MCF-7) and the non-cancerous (WI-38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc-1 and MCF-7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC = 61 μg/μL), comparable to the reference drug amantadine (TC = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H-bonding and π-π stacking, with binding affinities between -4.8558 and - 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug-like characteristics, but analogues 4a-d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. Twelve thiazole-pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2-((4-acetylphenyl)amino)-4-methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge-transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc-1, HT-29, MCF-7) and the non-cancerous (WI-38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc-1 and MCF-7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC50 = 61 μg/μL), comparable to the reference drug amantadine (TC50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H-bonding and π-π stacking, with binding affinities between -4.8558 and - 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug-like characteristics, but analogues 4a-d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications.Twelve thiazole-pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2-((4-acetylphenyl)amino)-4-methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge-transfer (CT) may be denoted as π → π* and n → π*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc-1, HT-29, MCF-7) and the non-cancerous (WI-38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc-1 and MCF-7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC50 = 61 μg/μL), comparable to the reference drug amantadine (TC50 = 72 μg/μL, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H-bonding and π-π stacking, with binding affinities between -4.8558 and - 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug-like characteristics, but analogues 4a-d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. Twelve thiazole-pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core, 2-((4-acetylphenyl)amino)-4-methylthiazole (2), through many synthetic approaches. The density functional theory (DFT) study of the synthesized analogues revealed coincided configurations of their highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO), except for the nitro derivatives, in which the intramolecular charge-transfer (CT) may be denoted as pi -> pi* and n -> pi*. In addition, the in vitro antiproliferative efficacy towards some cancer cell lines was examined (Panc-1, HT-29, MCF-7) and the non-cancerous (WI-38), using Dasatinib (Reference). The analogues 4c and 4d demonstrated the most potent anticancer effect, particularly against Panc-1 and MCF-7 cells. Moreover, the antiviral activity against H5N1, using a plaque reduction assay, showed that analogue 6a exhibited the most potent antiviral activity (100% inhibition and TC50 = 61 mu g/mu L), comparable to the reference drug amantadine (TC50 = 72 mu g/mu L, 100% inhibition). Furthermore, the molecular docking disclosed that the analogues exhibited a range of interactions, such as H-bonding and pi-pi stacking, with binding affinities between -4.8558 and - 8.3673 kcal/mol. Additionally, the SwissADME predictions indicated that the synthesized analogues possess promising drug-like characteristics, but analogues 4a-d and 8c demonstrated inadequate solubility and bioavailability, which restricts their use as viable oral medications. |
ArticleNumber | 70090 |
Author | Imam, Mohammed A. Almughathawi, Renad Alsharif, Shaker T. Alshammari, Nadiyah M. Halawani, Nuha M. El‐Metwaly, Nashwa M. Attar, Roba M. S. Siddiq, Hind A. |
Author_xml | – sequence: 1 givenname: Hind A. surname: Siddiq fullname: Siddiq, Hind A. organization: Jazan University – sequence: 2 givenname: Mohammed A. surname: Imam fullname: Imam, Mohammed A. organization: Umm Al‐Qura University – sequence: 3 givenname: Shaker T. surname: Alsharif fullname: Alsharif, Shaker T. organization: Umm Al‐Qura University – sequence: 4 givenname: Roba M. S. surname: Attar fullname: Attar, Roba M. S. organization: University of Jeddah – sequence: 5 givenname: Renad surname: Almughathawi fullname: Almughathawi, Renad organization: Taibah University – sequence: 6 givenname: Nadiyah M. surname: Alshammari fullname: Alshammari, Nadiyah M. organization: Qassim University – sequence: 7 givenname: Nuha M. surname: Halawani fullname: Halawani, Nuha M. organization: Umm Al Qura University – sequence: 8 givenname: Nashwa M. orcidid: 0000-0002-0619-6206 surname: El‐Metwaly fullname: El‐Metwaly, Nashwa M. email: nmmohamed@uqu.edu.sa, n_elmetwaly00@yahoo.com organization: Mansoura University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40087811$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc9u1DAQxi3Uiv6BCw-AfETQbceJs0l6W7KlRWoBqeUcOfa4NfLaxU5abaVKPALPyJPU6S57RPji8fg3o2_m2yNbzjsk5A2DQ5bOkeyUOiwBanhBdlnJywlkVbG1ictyh-zF-AOA8yKrXpIdDlCVFWO75PFy6fobjCZSr-kXvKdXN0Y8eIt_fv3-tgzPIZ05Yf31gPGYXqS3HKwIKVJorXHXB-m_N7fBW6MxiN7c4dGYuTNBWDqTY9QbjAdUOEVn84sTetkPKmVekW0tbMTX63uffP90ctWcTc6_nn5uZucTmdUAk7KrasAu06iwKPI6DTxlU-QyU0qIQqDmHITWIDvdAeNQyxprzutM55Ihz_fJu1XfJPJnGqNvFybKpF449ENsc1aW0yzL8iKhb9fo0C1QtbfBLERYtn9XloD3K0AGH2NAvUEYtKMf7ehH--xHgj-s4HvsvI7SoJO4KYCkdXQEppDO2Lr6f7oxfVq1d40fXJ9K2brUWFz-Q1LbfJzPV-KeAMJ-r-8 |
Cites_doi | 10.1016/j.ejmech.2022.114661 10.1016/j.molstruc.2022.133926 10.1016/j.saa.2008.01.010 10.1016/j.molstruc.2018.02.057 10.1016/j.saa.2011.05.052 10.3390/molecules28145359 10.1016/j.arabjc.2020.11.020 10.1021/jm7012024 10.1002/jhet.3970 10.1063/1.464913 10.1016/j.molstruc.2023.136194 10.1016/j.molstruc.2021.130526 10.1016/j.molstruc.2007.11.056 10.1016/j.molstruc.2021.131465 10.1016/j.apsusc.2018.05.007 10.1016/j.saa.2014.08.039 10.1016/j.bmcl.2012.08.073 10.3390/molecules21060748 10.3390/molecules23123074 10.1016/j.arabjc.2022.103898 10.1016/j.cplett.2003.09.115 10.32604/or.2024.047042 10.1016/j.ejmech.2016.02.030 10.1016/j.ejmech.2008.01.021 10.1515/psr-2021-0217 10.1007/s00214-022-02882-w 10.1021/jp0653611 10.1016/j.ejmech.2009.03.038 10.2147/DDDT.S356988 10.1016/j.ejmech.2014.12.031 10.2174/1570180814666170512122832 10.1016/j.bioorg.2022.105855 10.1021/acs.joc.1c03119 10.1016/j.ejmech.2015.11.002 10.1016/j.molstruc.2022.134728 10.1016/j.molstruc.2023.136609 10.1038/s41598-022-10253-5 10.1103/PhysRevA.77.013201 10.1016/j.bioorg.2020.103882 10.1021/jp036416r 10.3390/molecules27133994 10.1016/j.ejmech.2023.115699 10.1039/d0cs00196a 10.1016/j.ejmech.2009.01.032 10.2174/1574892810666150708110432 10.1016/0022-1759(86)90215-2 10.1103/physrevb.46.12947 10.1039/D0CS00196A 10.1103/PhysRevB.37.785 10.1038/s41598‐022‐10253‐5 10.1007/s00214‐022‐02882‐w 10.31788/RJC.2022.1536924 10.2174/18741045-v16-e2202280 10.1016/j.matpr.2022.09.150 |
ContentType | Journal Article |
Copyright | 2025 John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2025 John Wiley & Sons Ltd. |
DBID | 17B 1KM BLEPL DTL EGQ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/cbdd.70090 |
DatabaseName | Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | Web of Science CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Web of Science |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1747-0285 |
EndPage | n/a |
ExternalDocumentID | 40087811 10_1111_cbdd_70090 001445280600001 CBDD70090 |
Genre | researchArticle Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OC 29B 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGOF ACMXC ACPOU ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFWVQ AFZJQ AGHNM AHBTC AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EJD EMB EMK EMOBN EPT EST ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA HF~ HGLYW HVGLF HZI IHE IX1 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N9A NDZJH O66 OIG OVD P2W P4B P4D Q.N Q11 QB0 Q~Q R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WIH WIJ WIK WNSPC WOHZO WOW WQJ WXI WXSBR WYISQ XG1 ~IA ~KM ~WT 17B 1KM 1OB AAMMB AEFGJ AGXDD AGYGG AIDQK AIDYY BLEPL DTL GROUPED_WOS_WEB_OF_SCIENCE AAYXX AGQPQ CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c2900-7b890eb2fede5539cbd616e4c2ddaa5aef440aff0cbfb01409c9e94492f3c1e43 |
IEDL.DBID | DR2 |
ISICitedReferencesCount | 1 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=001445280600001 |
ISSN | 1747-0277 1747-0285 |
IngestDate | Fri Jul 11 09:54:31 EDT 2025 Wed Mar 26 04:38:47 EDT 2025 Tue Jul 01 05:07:23 EDT 2025 Wed Aug 06 10:48:24 EDT 2025 Fri Aug 29 16:03:23 EDT 2025 Mon Mar 24 09:20:58 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | DFT FMO's energies OPTICAL-PROPERTIES phenyl hydrazine SwissADME antiproliferative DERIVATIVES Thiazole-pyrazoles ELECTRONIC-STRUCTURE Thiazole‐pyrazoles |
Language | English |
License | 2025 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c2900-7b890eb2fede5539cbd616e4c2ddaa5aef440aff0cbfb01409c9e94492f3c1e43 |
Notes | The authors received no specific funding for this work. Funding ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-0619-6206 0009-0009-5210-0795 0009-0008-9004-2154 |
PMID | 40087811 |
PQID | 3177622235 |
PQPubID | 23479 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_3177622235 crossref_primary_10_1111_cbdd_70090 pubmed_primary_40087811 webofscience_primary_001445280600001 wiley_primary_10_1111_cbdd_70090_CBDD70090 webofscience_primary_001445280600001CitationCount |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2025 2025-03-01 2025-03-00 2025-Mar 20250301 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: March 2025 |
PublicationDecade | 2020 |
PublicationPlace | HOBOKEN |
PublicationPlace_xml | – name: HOBOKEN – name: England |
PublicationTitle | Chemical biology & drug design |
PublicationTitleAbbrev | CHEM BIOL DRUG DES |
PublicationTitleAlternate | Chem Biol Drug Des |
PublicationYear | 2025 |
Publisher | Wiley |
Publisher_xml | – name: Wiley |
References | 2009; 44 2013; 1 2021; 1239 2016; 107 2023; 8 1988; 37 2022; 1248 2022; 69 2024; 32 2020; 57 2008; 77 2008; 71 2022; 27 2018; 452 2022; 241 2023; 28 2015; 137 2016; 113 2024; 1295 2023; 259 1992; 46 2012; 22 2022; 124 1986; 94 2015; 92 2011; 81 2023; 1275 2015; 10 2009 2008; 888 2006; 110 2020; 100 2022; 87 2021; 50 2018; 23 2004; 108 2008; 51 2022; 1270 2011; 5 2021; 14 2022; 141 1993; 98 2018; 1161 2022; 12 2016; 21 2003; 381 2022; 15 2017 2023; 1292 2008; 43 2022; 16 2018; 15 Morigi, R (WOS:000361741000004) 2015; 10 Delley, B (WOS:000242826600036) 2006; 110 GERLIER, D (WOS:A1986E921700009) 1986; 94 Chugh, Vaishali (INSPEC:23571747) 2022 Rahman, SMA (WOS:001053156400001) 2023; 259 Qadir, T. (001445280600001.41) 2022; 16 Nossier, ES (WOS:000454523000024) 2018; 23 Abu-Melha, S (WOS:000793661200001) 2022; 15 Wahan, SK (WOS:000743443200001) 2022 Rana, R (WOS:001047507600001) 2023; 1292 Yang, XC (WOS:000806650200005) 2022; 124 Karamanis, P (WOS:000252862000115) 2008; 77 Bouchoucha, A (WOS:000428972900038) 2018; 1161 Othman, IMM (WOS:000848422000010) 2022; 1270 Mishra, CB (WOS:000350919100001) 2015; 92 Abraham, JP (WOS:000261046200012) 2008; 71 Arshad, MF (WOS:000824141600001) 2022; 27 Dua, R. (001445280600001.21) 2011; 5 Sivaiah, G (WOS:000904842000002) 2023; 1275 Zhou, HY (WOS:000253784900016) 2008; 51 Domingo, LR (WOS:000378757600074) 2016; 21 Dennington, R. (001445280600001.18) 2009 Sun, YL (WOS:000186598200022) 2003; 381 PERDEW, JP (WOS:A1992KA57700002) 1992; 46 Alqahtani, AM (WOS:000600978600016) 2021; 14 Al-Warhi, T (WOS:000802911500004) 2022; 16 Tawfik, SS (WOS:000427476800004) 2018; 15 Havrylyuk, D (WOS:000374609000012) 2016; 113 Aziz, M (WOS:000783491800005) 2022; 12 Abdel-Aziz, M (WOS:000268744700014) 2009; 44 Modric, M (WOS:000663587400007) 2021; 1239 Shah, MS (WOS:000703670300010) 2022; 1248 Xavier, S (WOS:000347269900042) 2015; 137 Jacob, PJ (WOS:000540965300004) 2020; 100 Han, B (WOS:000618380600020) 2021; 50 LEE, CT (WOS:A1988L976200011) 1988; 37 Bhusare, N (WOS:001223102500002) 2024; 32 El-Sabbagh, OI (WOS:000268744700048) 2009; 44 Frisch, M. (001445280600001.24) 2009 Depa, N. (001445280600001.19) 2022; 15 Bulat, FA (WOS:000187951600013) 2004; 108 BIOVIA Discovery Studio (001445280600001.13) 2017 Turan-Zitouni, G (WOS:000366780500022) 2016; 107 Shelke, SH (WOS:000309609500012) 2012; 22 Xia, Y (WOS:000261157100009) 2008; 43 Alalawy, AI (WOS:001077703000001) 2024; 1295 Sabry, MA (WOS:000841266800003) 2022; 241 Sajan, D (WOS:000296675000014) 2011; 81 Ben Ahmed, A (WOS:000260270200023) 2008; 888 Makhlouf, MM (WOS:000433203600038) 2018; 452 Fernández, NLG (WOS:000784116400018) 2022; 87 Parajuli, R. R. (001445280600001.39) 2013; 1 Mishra, I (WOS:000522305100001) 2020; 57 BECKE, AD (WOS:A1993KV99700048) 1993; 98 Afolabi, SO (WOS:000778976800001) 2022; 141 Nitulescu, GM (WOS:001036758000001) 2023; 28 e_1_2_7_5_1 e_1_2_7_3_1 e_1_2_7_9_1 Dua R. (e_1_2_7_22_1) 2011; 5 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_17_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_50_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_39_1 e_1_2_7_6_1 Frisch M. (e_1_2_7_25_1) 2009 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_10_1 e_1_2_7_46_1 Parajuli R. R. (e_1_2_7_40_1) 2013; 1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 |
References_xml | – year: 2009 – volume: 259 year: 2023 article-title: Current Development of 1, 2, 3‐Triazole Derived Potential Antimalarial Scaffolds: Structure Activity Relationship (SAR) and Bioactive Compounds publication-title: European Journal of Medicinal Chemistry – volume: 5 start-page: 120 issue: 3 year: 2011 end-page: 144 article-title: Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review publication-title: Advances in Biological Research – volume: 15 start-page: 363 issue: 4 year: 2018 end-page: 374 article-title: Synthesis and Anti‐Influenza Activity of Novel Thiadiazole, Oxadiazole and Triazole Based Scaffolds publication-title: Letters in Drug Design & Discovery – volume: 241 year: 2022 article-title: New Thiazole‐Based Derivatives as EGFR/HER2 and DHFR Inhibitors: Synthesis, Molecular Modeling Simulations and Anticancer Activity publication-title: European Journal of Medicinal Chemistry – volume: 124 year: 2022 article-title: Coumarin Thiazoles as Unique Structural Skeleton of Potential Antimicrobial Agents publication-title: Bioorganic Chemistry – volume: 1248 year: 2022 article-title: Synthesis, Antimicrobial and Antioxidant Evaluation With In Silico Studies of New Thiazole Schiff Base Derivatives publication-title: Journal of Molecular Structure – volume: 87 start-page: 4680 issue: 7 year: 2022 end-page: 4691 article-title: Ability of Boron to Act as a Nucleophile and an Electrophile in Boryl Shift Reactions Unveiled by Electron Density Distribution Analysis publication-title: Journal of Organic Chemistry – volume: 1 start-page: 5 issue: 1 year: 2013 end-page: 13 article-title: Pharmacological Activities of Pyrazolone Derivatives publication-title: Journal of Applied Pharmaceutical Research – volume: 14 issue: 1 year: 2021 article-title: Synthesis and Antiproliferative Activity Studies of New Functionalized Pyridine Linked Thiazole Derivatives publication-title: Arabian Journal of Chemistry – volume: 50 start-page: 1522 issue: 3 year: 2021 end-page: 1586 article-title: Asymmetric Organocatalysis: An Enabling Technology for Medicinal Chemistry publication-title: Chemical Society Reviews – volume: 94 start-page: 57 issue: 1–2 year: 1986 end-page: 63 article-title: Use of MTT Colorimetric Assay to Measure Cell Activation publication-title: Journal of Immunological Methods – volume: 1275 year: 2023 article-title: Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Pyrrolo [2, 3‐d] Pyrimidin‐2‐Amine Derivatives as EGFR Inhibitors publication-title: Journal of Molecular Structure – volume: 452 start-page: 337 year: 2018 end-page: 351 article-title: Experimental and DFT Insights Into Molecular Structure and Optical Properties of New Chalcones as Promising Photosensitizers Towards Solar Cell Applications publication-title: Applied Surface Science – volume: 16 start-page: 1457 year: 2022 end-page: 1471 article-title: Novel 2‐(5‐Aryl‐4, 5‐Dihydropyrazol‐1‐Yl) Thiazol‐4‐One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights publication-title: Drug Design, Development and Therapy – volume: 137 start-page: 306 year: 2015 end-page: 320 article-title: NBO, Conformational, NLO, HOMO–LUMO, NMR and Electronic Spectral Study on 1‐Phenyl‐1‐Propanol by Quantum Computational Methods publication-title: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy – volume: 23 issue: 12 year: 2018 article-title: Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives publication-title: Molecules – volume: 381 start-page: 397 issue: 3–4 year: 2003 end-page: 403 article-title: Nanoring Structure and Optical Properties of Ga8As8 publication-title: Chemical Physics Letters – volume: 1161 start-page: 345 year: 2018 end-page: 355 article-title: Synthesis and Characterization of New Complexes of Nickel (II), Palladium (II) and Platinum(II) With Derived Sulfonamide Ligand: Structure, DFT Study, Antibacterial and Cytotoxicity Activities publication-title: Journal of Molecular Structure – volume: 77 issue: 1 year: 2008 article-title: Structure, Stability, Dipole Polarizability and Differential Polarizability in Small Gallium Arsenide Clusters From All‐Electron Ab Initio and Density‐Functional‐Theory Calculations publication-title: Physical Review A: Atomic, Molecular, and Optical Physics – volume: 15 issue: 7 year: 2022 article-title: Molecular Modeling and Docking Studies of New Antimicrobial Antipyrine‐Thiazole Hybrids publication-title: Arabian Journal of Chemistry – volume: 92 start-page: 1 year: 2015 end-page: 34 article-title: Thiazole: A Promising Heterocycle for the Development of Potent CNS Active Agents publication-title: European Journal of Medicinal Chemistry – volume: 44 start-page: 3480 issue: 9 year: 2009 end-page: 3487 article-title: Synthesis of Novel Pyrazole Derivatives and Evaluation of Their Antidepressant and Anticonvulsant Activities publication-title: European Journal of Medicinal Chemistry – volume: 1270 year: 2022 article-title: Chemical Synthesis and Molecular Docking Study of New Thiazole, Thiophene, and Thieno [2, 3‐d] Pyrimidine Derivatives as Potential Antiproliferative and Antimicrobial Agents publication-title: Journal of Molecular Structure – volume: 37 start-page: 785 issue: 2 year: 1988 end-page: 789 article-title: Development of the Colle‐Salvetti Correlation‐Energy Formula Into a Functional of the Electron Density publication-title: Physical Review B: Condensed Matter – volume: 32 start-page: 849 issue: 5 year: 2024 end-page: 875 article-title: A Review on Potential Heterocycles for the Treatment of Glioblastoma Targeting Receptor Tyrosine Kinases publication-title: Oncology Research – volume: 22 start-page: 6373 issue: 20 year: 2012 end-page: 6376 article-title: Synthesis and Pharmacological Evaluation of a Novel Series of 3‐Aryl‐2‐(2‐Substituted‐4‐Methylthiazole‐5‐Yl) Thiazolidin‐4‐One as Possible Anti‐Inflammatory and Antimicrobial Agents publication-title: Bioorganic & Medicinal Chemistry Letters – volume: 141 start-page: 1 issue: 4 year: 2022 end-page: 14 article-title: Quantum Study on the Optoelectronic Properties and Chemical Reactivity of Phenoxazine‐Based Organic Photosensitizer for Solar Cell Purposes publication-title: Theoretical Chemistry Accounts – volume: 110 start-page: 13632 issue: 50 year: 2006 end-page: 13639 article-title: Ground‐State Enthalpies: Evaluation of Electronic Structure Approaches With Emphasis on the Density Functional Method publication-title: Journal of Physical Chemistry A – volume: 1295 year: 2024 article-title: Synthesis, Molecular Modeling, and Anticancer Activity of New Thiophene and Thiophene‐Pyrazole Analogues Incorporating Benzene‐Sulfonamide Moiety as Carbonic Anhydrase Isozymes (CA‐IX and CA‐XII) publication-title: Journal of Molecular Structure – volume: 15 start-page: 1709 issue: 3 year: 2022 end-page: 1717 article-title: Synthesis and Biological Active Compounds of Nitrogen‐Containing Heterocyclic Compounds: A Review publication-title: Rasayan Journal of Chemistry – volume: 57 start-page: 2304 issue: 6 year: 2020 end-page: 2329 article-title: A Retrospect on Antimicrobial Potential of Thiazole Scaffold publication-title: Journal of Heterocyclic Chemistry – volume: 44 start-page: 3746 issue: 9 year: 2009 end-page: 3753 article-title: Synthesis and Antiviral Activity of New Pyrazole and Thiazole Derivatives publication-title: European Journal of Medicinal Chemistry – volume: 107 start-page: 288 year: 2016 end-page: 294 article-title: Synthesis and Evaluation of Bis‐Thiazole Derivatives as New Anticancer Agents publication-title: European Journal of Medicinal Chemistry – volume: 43 start-page: 2347 issue: 11 year: 2008 end-page: 2353 article-title: Synthesis and Structure–Activity Relationships of Novel 1‐Arylmethyl‐3‐Aryl‐1H‐Pyrazole‐5‐Carbohydrazide Hydrazone Derivatives as Potential Agents Against A549 Lung Cancer Cells publication-title: European Journal of Medicinal Chemistry – volume: 108 start-page: 342 issue: 2 year: 2004 end-page: 349 article-title: Condensation of Frontier Molecular Orbital Fukui Functions publication-title: Journal of Physical Chemistry A – volume: 8 start-page: 3043 issue: 10 year: 2023 end-page: 3065 article-title: Recent Advances of Heterocycle Based Anticancer Hybrids publication-title: Physical Sciences Reviews – volume: 98 start-page: 5648 issue: 7 year: 1993 end-page: 5652 article-title: Density‐Functional Thermochemistry. III. The Role of Exact Exchange publication-title: Journal of Chemical Physics – volume: 21 issue: 6 year: 2016 article-title: Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity publication-title: Molecules – volume: 71 start-page: 355 issue: 2 year: 2008 end-page: 367 article-title: Molecular Structure, Spectroscopic Studies and First‐Order Molecular Hyperpolarizabilities of p‐Amino Acetanilide publication-title: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy – volume: 113 start-page: 145 year: 2016 end-page: 166 article-title: Synthetic Approaches, Structure Activity Relationship and Biological Applications for Pharmacologically Attractive Pyrazole/Pyrazoline–Thiazolidine‐Based Hybrids publication-title: European Journal of Medicinal Chemistry – volume: 1292 year: 2023 article-title: A Comprehensive Review on Thiazole Based Conjugates as Anti‐Cancer Agents publication-title: Journal of Molecular Structure – volume: 12 start-page: 6404 issue: 1 year: 2022 article-title: Identification of Potent Inhibitors of NEK7 Protein Using a Comprehensive Computational Approach publication-title: Scientific Reports – volume: 100 year: 2020 article-title: Identification and Development of Thiazole Leads as COX‐2/5‐LOX Inhibitors Through In‐Vitro and In‐Vivo Biological Evaluation for Anti‐Inflammatory Activity publication-title: Bioorganic Chemistry – volume: 81 start-page: 85 issue: 1 year: 2011 end-page: 98 article-title: Natural Bond Orbital Analysis, Electronic Structure, Non‐Linear Properties and Vibrational Spectral Analysis of L‐Histidinium Bromide Monohydrate: A Density Functional Theory publication-title: Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy – volume: 1239 year: 2021 article-title: Design, Synthesis and Biological Evaluation of New 1, 3‐Thiazole Derivatives as Potential Anti‐Inflammatory Agents publication-title: Journal of Molecular Structure – volume: 27 issue: 13 year: 2022 article-title: Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents publication-title: Molecules – volume: 10 start-page: 280 issue: 3 year: 2015 end-page: 297 article-title: Recent Patents on Thiazole Derivatives Endowed With Antitumor Activity publication-title: Recent Patents on Anti‐Cancer Drug Discovery – volume: 28 issue: 14 year: 2023 article-title: The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies publication-title: Molecules – year: 2017 – volume: 69 start-page: 478 year: 2022 end-page: 481 article-title: Heterocyclic Compounds Containing Thiazole Ring as Important Material in Medicinal Chemistry publication-title: Materials Today Proceedings – volume: 51 start-page: 1242 issue: 5 year: 2008 end-page: 1251 article-title: Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug‐Resistant Lung Cancer Cells publication-title: Journal of Medicinal Chemistry – volume: 46 start-page: 12947 issue: 20 year: 1992 end-page: 12954 article-title: Pair‐Distribution Function and Its Coupling‐Constant Average for the Spin‐Polarized Electron Gas publication-title: Physical Review B: Condensed Matter – volume: 16 issue: 1 year: 2022 article-title: A Review on Medicinally Important Heterocyclic Compounds publication-title: Open Medicinal Chemistry Journal – volume: 888 start-page: 180 issue: 1–3 year: 2008 end-page: 186 article-title: Structural, Vibrational and Theoretical Studies of L‐Histidine Bromide publication-title: Journal of Molecular Structure – volume: 241 start-page: ARTN 114661 year: 2022 ident: WOS:000841266800003 article-title: New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2022.114661 – volume: 1270 start-page: ARTN 133926 year: 2022 ident: WOS:000848422000010 article-title: Chemical synthesis and molecular docking study of new thiazole, thiophene, and thieno[2,3-d]pyrimidine derivatives as potential antiproliferative and antimicrobial agents publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2022.133926 – volume: 71 start-page: 355 year: 2008 ident: WOS:000261046200012 article-title: Molecular structure, spectroscopic studies and first-order molecular hyperpolarizabilities of p-amino acetanilide publication-title: SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY doi: 10.1016/j.saa.2008.01.010 – volume: 94 start-page: 57 year: 1986 ident: WOS:A1986E921700009 article-title: USE OF MTT COLORIMETRIC ASSAY TO MEASURE CELL ACTIVATION publication-title: JOURNAL OF IMMUNOLOGICAL METHODS – volume: 1161 start-page: 345 year: 2018 ident: WOS:000428972900038 article-title: Synthesis and characterization of new complexes of nickel (II), palladium (II) and platinum(II) with derived sulfonamide ligand: Structure, DFT study, antibacterial and cytotoxicity activities publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2018.02.057 – volume: 81 start-page: 85 year: 2011 ident: WOS:000296675000014 article-title: Natural bond orbital analysis, electronic structure, non-linear properties and vibrational spectral analysis of L-histidinium bromide monohydrate: A density functional theory publication-title: SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY doi: 10.1016/j.saa.2011.05.052 – volume: 28 start-page: ARTN 5359 year: 2023 ident: WOS:001036758000001 article-title: The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies publication-title: MOLECULES doi: 10.3390/molecules28145359 – year: 2017 ident: 001445280600001.13 publication-title: Materials Studio. – volume: 14 start-page: ARTN 102914 year: 2021 ident: WOS:000600978600016 article-title: Synthesis and antiproliferative activity studies of new functionalized pyridine linked thiazole derivatives publication-title: ARABIAN JOURNAL OF CHEMISTRY doi: 10.1016/j.arabjc.2020.11.020 – volume: 51 start-page: 1242 year: 2008 ident: WOS:000253784900016 article-title: Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm7012024 – volume: 37 start-page: 785 year: 1988 ident: WOS:A1988L976200011 article-title: DEVELOPMENT OF THE COLLE-SALVETTI CORRELATION-ENERGY FORMULA INTO A FUNCTIONAL OF THE ELECTRON-DENSITY publication-title: PHYSICAL REVIEW B – volume: 57 start-page: 2304 year: 2020 ident: WOS:000522305100001 article-title: A retrospect on antimicrobial potential of thiazole scaffold publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY doi: 10.1002/jhet.3970 – start-page: 478 year: 2022 ident: INSPEC:23571747 article-title: Heterocyclic compounds containing thiazole ring as important material in medicinal chemistry publication-title: Materials Today: Proceedings – volume: 5 start-page: 120 year: 2011 ident: 001445280600001.21 article-title: Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review publication-title: Advances in Biological Research – volume: 98 start-page: 5648 year: 1993 ident: WOS:A1993KV99700048 article-title: Density-functional thermochemistry. III. The role of exact exchange publication-title: JOURNAL OF CHEMICAL PHYSICS doi: 10.1063/1.464913 – volume: 1292 start-page: ARTN 136194 year: 2023 ident: WOS:001047507600001 article-title: A comprehensive review on thiazole based conjugates as anti-cancer agents publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2023.136194 – volume: 1239 start-page: ARTN 130526 year: 2021 ident: WOS:000663587400007 article-title: Design, synthesis and biological evaluation of new 1,3-thiazole derivatives as potential anti-inflammatory agents publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2021.130526 – volume: 888 start-page: 180 year: 2008 ident: WOS:000260270200023 article-title: Structural, vibrational and theoretical studies of L-histidine bromide publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2007.11.056 – volume: 1248 start-page: ARTN 131465 year: 2022 ident: WOS:000703670300010 article-title: Synthesis, antimicrobial and antioxidant evaluation with in silico studies of new thiazole Schiff base derivatives publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2021.131465 – volume: 452 start-page: 337 year: 2018 ident: WOS:000433203600038 article-title: Experimental and DFT insights into molecular structure and optical properties of new chalcones as promising photosensitizers towards solar cell applications publication-title: APPLIED SURFACE SCIENCE doi: 10.1016/j.apsusc.2018.05.007 – volume: 137 start-page: 306 year: 2015 ident: WOS:000347269900042 article-title: NBO, conformational, NLO, HOMO-LUMO, NMR and electronic spectral study on 1-phenyl-1-propanol by quantum computational methods publication-title: SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY doi: 10.1016/j.saa.2014.08.039 – volume: 22 start-page: 6373 year: 2012 ident: WOS:000309609500012 article-title: Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl)thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2012.08.073 – volume: 21 start-page: ARTN 748 year: 2016 ident: WOS:000378757600074 article-title: Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity publication-title: MOLECULES doi: 10.3390/molecules21060748 – volume: 23 start-page: ARTN 3074 year: 2018 ident: WOS:000454523000024 article-title: Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives publication-title: MOLECULES doi: 10.3390/molecules23123074 – volume: 15 start-page: ARTN 103898 year: 2022 ident: WOS:000793661200001 article-title: Molecular modeling and docking studies of new antimicrobial antipyrine-thiazole hybrids publication-title: ARABIAN JOURNAL OF CHEMISTRY doi: 10.1016/j.arabjc.2022.103898 – volume: 1 start-page: 5 year: 2013 ident: 001445280600001.39 article-title: Pharmacological Activities of Pyrazolone Derivatives publication-title: Journal of Applied Pharmaceutical Research – volume: 15 start-page: 1709 year: 2022 ident: 001445280600001.19 article-title: Synthesis and Biological Active Compounds of NitrogenContaining Heterocyclic Compounds: A Review publication-title: Rasayan Journal of Chemistry – volume: 381 start-page: 397 year: 2003 ident: WOS:000186598200022 article-title: Nanoring structure and optical properties of Ga8As8 publication-title: CHEMICAL PHYSICS LETTERS doi: 10.1016/j.cplett.2003.09.115 – volume: 46 start-page: 12947 year: 1992 ident: WOS:A1992KA57700002 article-title: PAIR-DISTRIBUTION FUNCTION AND ITS COUPLING-CONSTANT AVERAGE FOR THE SPIN-POLARIZED ELECTRON-GAS publication-title: PHYSICAL REVIEW B – volume: 32 start-page: 849 year: 2024 ident: WOS:001223102500002 article-title: A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases publication-title: ONCOLOGY RESEARCH doi: 10.32604/or.2024.047042 – volume: 113 start-page: 145 year: 2016 ident: WOS:000374609000012 article-title: Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2016.02.030 – volume: 43 start-page: 2347 year: 2008 ident: WOS:000261157100009 article-title: Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2008.01.021 – year: 2022 ident: WOS:000743443200001 article-title: Recent advances of heterocycle based anticancer hybrids publication-title: PHYSICAL SCIENCES REVIEWS doi: 10.1515/psr-2021-0217 – volume: 141 start-page: ARTN 22 year: 2022 ident: WOS:000778976800001 article-title: Quantum study on the optoelectronic properties and chemical reactivity of phenoxazine-based organic photosensitizer for solar cell purposes publication-title: THEORETICAL CHEMISTRY ACCOUNTS doi: 10.1007/s00214-022-02882-w – volume: 110 start-page: 13632 year: 2006 ident: WOS:000242826600036 article-title: Ground-state enthalpies: Evaluation of electronic structure approaches with emphasis on the density functional method publication-title: JOURNAL OF PHYSICAL CHEMISTRY A doi: 10.1021/jp0653611 – volume: 44 start-page: 3746 year: 2009 ident: WOS:000268744700048 article-title: Synthesis and antiviral activity of new pyrazole and thiazole derivatives publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2009.03.038 – volume: 16 start-page: 1457 year: 2022 ident: WOS:000802911500004 article-title: Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights publication-title: DRUG DESIGN DEVELOPMENT AND THERAPY doi: 10.2147/DDDT.S356988 – volume: 92 start-page: 1 year: 2015 ident: WOS:000350919100001 article-title: Thiazole: A promising heterocycle for the development of potent CNS active agents publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2014.12.031 – volume: 15 start-page: 363 year: 2018 ident: WOS:000427476800004 article-title: Synthesis and Anti-influenza Activity of Novel Thiadiazole, Oxadiazole and Triazole Based Scaffolds publication-title: LETTERS IN DRUG DESIGN & DISCOVERY doi: 10.2174/1570180814666170512122832 – volume: 124 start-page: ARTN 105855 year: 2022 ident: WOS:000806650200005 article-title: Coumarin thiazoles as unique structural skeleton of potential antimicrobial agents publication-title: BIOORGANIC CHEMISTRY doi: 10.1016/j.bioorg.2022.105855 – volume: 87 start-page: 4680 year: 2022 ident: WOS:000784116400018 article-title: Ability of Boron to Act as a Nucleophile and an Electrophile in BorylShift Reactions Unveiled by Electron Density Distribution Analysis publication-title: JOURNAL OF ORGANIC CHEMISTRY doi: 10.1021/acs.joc.1c03119 – volume: 107 start-page: 288 year: 2016 ident: WOS:000366780500022 article-title: Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2015.11.002 – volume: 16 year: 2022 ident: 001445280600001.41 article-title: A Review on Medicinally Important Heterocyclic Compounds publication-title: Open Medicinal Chemistry Journal – volume: 1275 start-page: ARTN 134728 year: 2023 ident: WOS:000904842000002 article-title: Synthesis, biological evaluation and molecular docking studies of novel pyrrolo[2,3-d]pyrimidin-2-amine derivatives as EGFR inhibitors publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2022.134728 – volume: 1295 start-page: ARTN 136609 year: 2024 ident: WOS:001077703000001 article-title: Synthesis, molecular modeling, and anticancer activity of new thiophene and thiophene-pyrazole analogues incorporating benzene-sulfonamide moiety as carbonic anhydrase isozymes (CA-IX and CA-XII) publication-title: JOURNAL OF MOLECULAR STRUCTURE doi: 10.1016/j.molstruc.2023.136609 – volume: 12 start-page: ARTN 6404 year: 2022 ident: WOS:000783491800005 article-title: Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach publication-title: SCIENTIFIC REPORTS doi: 10.1038/s41598-022-10253-5 – volume: 77 start-page: ARTN 013201 year: 2008 ident: WOS:000252862000115 article-title: Structure, stability, dipole polarizability and differential polarizability in small gallium arsenide clusters from all-electron ab initio and density-functional-theory calculations publication-title: PHYSICAL REVIEW A doi: 10.1103/PhysRevA.77.013201 – volume: 100 start-page: ARTN 103882 year: 2020 ident: WOS:000540965300004 article-title: Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in -vitro and in -vivo biological evaluation for anti-inflammatory activity publication-title: BIOORGANIC CHEMISTRY doi: 10.1016/j.bioorg.2020.103882 – volume: 108 start-page: 342 year: 2004 ident: WOS:000187951600013 article-title: Condensation of frontier molecular orbital Fukui functions publication-title: JOURNAL OF PHYSICAL CHEMISTRY A doi: 10.1021/jp036416r – year: 2009 ident: 001445280600001.24 publication-title: Gaussian 09W (Version Revision A. 1) – volume: 27 start-page: ARTN 3994 year: 2022 ident: WOS:000824141600001 article-title: Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents publication-title: MOLECULES doi: 10.3390/molecules27133994 – volume: 259 start-page: ARTN 115699 year: 2023 ident: WOS:001053156400001 article-title: Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2023.115699 – volume: 50 start-page: 1522 year: 2021 ident: WOS:000618380600020 article-title: Asymmetric organocatalysis: an enabling technology for medicinal chemistry publication-title: CHEMICAL SOCIETY REVIEWS doi: 10.1039/d0cs00196a – volume: 44 start-page: 3480 year: 2009 ident: WOS:000268744700014 article-title: Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities publication-title: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1016/j.ejmech.2009.01.032 – year: 2009 ident: 001445280600001.18 publication-title: GaussView – volume: 10 start-page: 280 year: 2015 ident: WOS:000361741000004 article-title: Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity publication-title: RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY doi: 10.2174/1574892810666150708110432 – ident: e_1_2_7_43_1 doi: 10.1016/j.ejmech.2023.115699 – ident: e_1_2_7_35_1 doi: 10.1016/j.molstruc.2021.130526 – ident: e_1_2_7_32_1 doi: 10.1016/j.bioorg.2020.103882 – ident: e_1_2_7_23_1 doi: 10.1016/j.ejmech.2009.03.038 – ident: e_1_2_7_53_1 doi: 10.1515/psr-2021-0217 – ident: e_1_2_7_38_1 doi: 10.3390/molecules23123074 – ident: e_1_2_7_26_1 doi: 10.1016/0022-1759(86)90215-2 – ident: e_1_2_7_2_1 doi: 10.1016/j.ejmech.2009.01.032 – ident: e_1_2_7_6_1 doi: 10.1016/j.molstruc.2007.11.056 – ident: e_1_2_7_37_1 doi: 10.3390/molecules28145359 – ident: e_1_2_7_8_1 doi: 10.1016/j.arabjc.2020.11.020 – ident: e_1_2_7_9_1 doi: 10.2147/DDDT.S356988 – ident: e_1_2_7_46_1 doi: 10.1016/j.saa.2011.05.052 – ident: e_1_2_7_56_1 doi: 10.1016/j.bioorg.2022.105855 – ident: e_1_2_7_18_1 doi: 10.1021/jp0653611 – ident: e_1_2_7_12_1 doi: 10.1063/1.464913 – ident: e_1_2_7_44_1 doi: 10.1016/j.molstruc.2023.136194 – ident: e_1_2_7_34_1 doi: 10.1002/jhet.3970 – volume: 1 start-page: 5 issue: 1 year: 2013 ident: e_1_2_7_40_1 article-title: Pharmacological Activities of Pyrazolone Derivatives publication-title: Journal of Applied Pharmaceutical Research – ident: e_1_2_7_19_1 – ident: e_1_2_7_41_1 doi: 10.1103/physrevb.46.12947 – ident: e_1_2_7_7_1 doi: 10.1016/j.molstruc.2023.136609 – ident: e_1_2_7_24_1 doi: 10.1021/acs.joc.1c03119 – ident: e_1_2_7_54_1 doi: 10.1016/j.saa.2014.08.039 – ident: e_1_2_7_27_1 doi: 10.1039/D0CS00196A – ident: e_1_2_7_30_1 doi: 10.1103/PhysRevB.37.785 – volume-title: Gaussian 09W (Version Revision A. 1) year: 2009 ident: e_1_2_7_25_1 – ident: e_1_2_7_11_1 doi: 10.1038/s41598‐022‐10253‐5 – volume: 5 start-page: 120 issue: 3 year: 2011 ident: e_1_2_7_22_1 article-title: Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review publication-title: Advances in Biological Research – ident: e_1_2_7_16_1 doi: 10.1021/jp036416r – ident: e_1_2_7_3_1 doi: 10.1016/j.saa.2008.01.010 – ident: e_1_2_7_14_1 – ident: e_1_2_7_50_1 doi: 10.1016/j.cplett.2003.09.115 – ident: e_1_2_7_31_1 doi: 10.1016/j.apsusc.2018.05.007 – ident: e_1_2_7_5_1 doi: 10.1007/s00214‐022‐02882‐w – ident: e_1_2_7_20_1 doi: 10.31788/RJC.2022.1536924 – ident: e_1_2_7_15_1 doi: 10.1016/j.molstruc.2018.02.057 – ident: e_1_2_7_21_1 doi: 10.3390/molecules21060748 – ident: e_1_2_7_33_1 doi: 10.1016/j.ejmech.2014.12.031 – ident: e_1_2_7_52_1 doi: 10.1016/j.ejmech.2015.11.002 – ident: e_1_2_7_51_1 doi: 10.2174/1570180814666170512122832 – ident: e_1_2_7_42_1 doi: 10.2174/18741045-v16-e2202280 – ident: e_1_2_7_36_1 doi: 10.2174/1574892810666150708110432 – ident: e_1_2_7_39_1 doi: 10.1016/j.molstruc.2022.133926 – ident: e_1_2_7_55_1 doi: 10.1016/j.ejmech.2008.01.021 – ident: e_1_2_7_29_1 doi: 10.1103/PhysRevA.77.013201 – ident: e_1_2_7_13_1 doi: 10.32604/or.2024.047042 – ident: e_1_2_7_17_1 doi: 10.1016/j.matpr.2022.09.150 – ident: e_1_2_7_47_1 doi: 10.1016/j.molstruc.2021.131465 – ident: e_1_2_7_49_1 doi: 10.1016/j.molstruc.2022.134728 – ident: e_1_2_7_28_1 doi: 10.1016/j.ejmech.2016.02.030 – ident: e_1_2_7_10_1 doi: 10.3390/molecules27133994 – ident: e_1_2_7_48_1 doi: 10.1016/j.bmcl.2012.08.073 – ident: e_1_2_7_4_1 doi: 10.1016/j.arabjc.2022.103898 – ident: e_1_2_7_45_1 doi: 10.1016/j.ejmech.2022.114661 – ident: e_1_2_7_57_1 doi: 10.1021/jm7012024 |
SSID | ssj0044528 |
Score | 2.410082 |
Snippet | ABSTRACT
Twelve thiazole‐pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core,... Twelve thiazole-pyrazole analogues 4, 6, and 8 were synthesized by introducing various pyrazole systems into the core,... Twelve thiazole‐pyrazole analogues 4 , 6 , and 8 were synthesized by introducing various pyrazole systems into the core,... |
Source | Web of Science |
SourceID | proquest pubmed crossref webofscience wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e70090 |
SubjectTerms | Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology antiproliferative Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Antiviral Agents - pharmacology Biochemistry & Molecular Biology Cell Line, Tumor Cell Proliferation - drug effects Chemistry, Medicinal Density Functional Theory FMO's energies Humans Life Sciences & Biomedicine MCF-7 Cells Models, Molecular Molecular Docking Simulation Pharmacology & Pharmacy phenyl hydrazine Pyrazoles - chemical synthesis Pyrazoles - chemistry Pyrazoles - pharmacology Science & Technology Structure-Activity Relationship SwissADME Thiazoles - chemical synthesis Thiazoles - chemistry Thiazoles - pharmacology Thiazole‐pyrazoles |
Title | Synthesis of New Thiazole‐Pyrazole Analogues: Molecular Modelling, Antiproliferative/Antiviral Activities, and ADME Studies |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcbdd.70090 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=001445280600001 https://www.ncbi.nlm.nih.gov/pubmed/40087811 https://www.proquest.com/docview/3177622235 |
Volume | 105 |
WOS | 001445280600001 |
WOSCitedRecordID | wos001445280600001 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CLs2lj6QPt01QaE4l3sq2ZK9CLsluQihsKW0CuRSjJ11avCH2HhIo9Cf0N-aXRCPbm0ehtL0JW7b1mNF8I42_AdhSzKVsKJPYMpvFTDgVC1lkHsgZ5fXLJkbiPuTkQ350wt6f8tMl2O3_hWn5IRYbbqgZYb1GBZeqvqXkWhkzKDxEQIcdg7UQEX1acEcxxkNiVY-4i3BQ2XGTYhjPzaN3rdFvEPOeNboLYIMFOnwEX_q2t4En3wbzRg305T1ax__t3GN42EFTstfK0hNYstUqPBj1GeHW4Mfni8rjxXpak5kjfnkkx1-n8nL23V79_PXx4jwUCdKc4H5QvUMmfe5dginXAvv3tr_fTM8wV5CzLev4O7yCscb-2zoks_De-zaRlSF748kB6UIdn8LJ4cHx6Cju0jfEOhWUxoUaCuodd2eN5TwTvk95klumU2Ok5NI6xqh0jmrlFDp6QgsrGBOpy3RiWfYMlqtZZV8AobkxNJeaU61ZUigppMtkzrlWyrFMR_Cmn8byrGXpKHvvBoeyDEMZwWY_w6UfOTwZkZWdzevSgyhvFDxS4hE8b6d-8R6GrH3DJIlg67YsLO6jk4myRvNwUhJB8jfVRh0DOzIPNBG8DcLwh7aXo_3xOJRe_kvlV7CSYsLiEDT3Gpab87ld9yiqURtBW64B8HUaFA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL1CZVE2vB8pLyO6Qs3USexkzK7MtBqgUyGYSt1FfooRVaZqMotWQuIT-Ea-BF8nGdoiIWBnxc7Dj2ufa9-cA7CpmEvZUCaxZTaLmXAqFrLIPJAzytuXTYzEfcjpQT45ZO-O-FEXm4P_wrT8EKsNN7SMMF-jgeOG9AUr18qYQeExgvfYr6Okd_CoPq7YoxjjQVrVY-4iHFV27KQYyPPr3svr0W8g88p6dBnChjVo71YrtFoH6kIMPfkyWDZqoM-vEDv-d_Vuw80OnZKddjjdgWu2ugvro14U7h58_XRWechYz2uycMTPkGT2eS7PF8f2x7fvH85OQ5Ig0wluCdWvybSX3yWouhYIwLd8fjM_QbkgZ1vi8W28guHG_t066Fl4B36LyMqQnfF0l3TRjvfhcG93NprEnYJDrFNBaVyooaDed3fWWM4z4euUJ7llOjVGSi6tY4xK56hWTqGvJ7SwgjGRukwnlmUPYK1aVPYREJobQ3OpOdWaJYWSQrpM5pxrpRzLdAQv-34sT1qijrJ3cLApy9CUEbzou7j0LYeHI7Kyi2Vdehzl1wUPlngED9u-Xz2HIXHfMEki2Lw4GFb56GfiYKN5OCyJIPmbYqOOhB3JB5oIXoXR8IdvL0dvxuOQ2viXws9hfTKb7pf7bw_eP4YbKeoXhxi6J7DWnC7tUw-qGvUsmM5PcqYeLw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5VRQJeuI9wGtEn1CxOYidrxEvZdFWOrSpopb6gyKdYgbKrbvahlZD4CfxGfgkeJ1naIiHgzUqcxMeM5xt78g3AhmIuZUOZxJbZLGbCqVjIIvNAziivXzYxEvchJ7v5zgF7c8gP1-Bl_y9Myw-x2nBDzQjrNSr43LhTSq6VMYPCQwTvsF9gOR2iTJfvV-RRjPGQWdVD7iKcVHbkpBjH8-vZs-boN4x5zhydRbDBBI2vwse-8W3kyefBslEDfXKO1_F_e3cNrnTYlGy1wnQd1mx9Ay6N-pRwN-Hrh-PaA8bFdEFmjvj1kex_msqT2Rf749v3veOjUCTIc4IbQosXZNIn3yWYcy3Qf2_6-810jsmCnG1px5_jFQw29t_WIZuFd983iawN2Son26SLdbwFB-Pt_dFO3OVviHUqKI0LNRTUe-7OGst5Jnyf8iS3TKfGSMmldYxR6RzVyin09IQWVjAmUpfpxLLsNqzXs9reBUJzY2guNadas6RQUkiXyZxzrZRjmY7gaT-N1byl6ah69waHsgpDGcGTfoYrP3J4NCJrO1suKo-ivFXwUIlHcKed-tV7GNL2DZMkgo3TsrC6j14myhrNw1FJBMnfVBt1FOxIPdBE8CwIwx_aXo1elWUo3fuXyo_h4l45rt693n17Hy6nmLw4BNA9gPXmaGkfekTVqEdBcX4CKF8c5w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+of+New+Thiazole%E2%80%90Pyrazole+Analogues%3A+Molecular+Modelling%2C+Antiproliferative%2FAntiviral+Activities%2C+and+ADME+Studies&rft.jtitle=Chemical+biology+%26+drug+design&rft.au=Siddiq%2C+Hind+A.&rft.au=Imam%2C+Mohammed+A.&rft.au=Alsharif%2C+Shaker+T.&rft.au=Attar%2C+Roba+M.+S.&rft.date=2025-03-01&rft.issn=1747-0277&rft.eissn=1747-0285&rft.volume=105&rft.issue=3&rft.epage=n%2Fa&rft_id=info:doi/10.1111%2Fcbdd.70090&rft.externalDBID=10.1111%252Fcbdd.70090&rft.externalDocID=CBDD70090 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1747-0277&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1747-0277&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1747-0277&client=summon |